Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondria! DNA Damage and Metabolism DisturbanceJOURNAL OF MEDICINAL CHEMISTRYIF6.82019-02-28106PREAI
Inhibition of autophagic flux by cyclometalated iridium(iii) complexes through anion transportationCHEMICAL SCIENCEIF7.42019-01-0151OAAI
Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic TherapyACS APPLIED MATERIALS & INTERFACESIF8.22017-11-28121PREAI
Light-Up Mitophagy in Live Cells with Dual-Functional Theranostic Phosphorescent Iridium(III) Complexes具有双功能治疗磷光铱 (III) 配合物的活细胞中的线粒体自噬ACS APPLIED MATERIALS & INTERFACESIF8.22017-04-0684PREAI
Tumor-targeted supramolecular nanoparticles self-assembled from a ruthenium-β-cyclodextrin complex and an adamantane-functionalized peptideCHEMICAL COMMUNICATIONSIF4.22017-01-0130PREAI
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(III) complexesCHEMICAL SCIENCEIF7.42017-01-01168OAAI
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer AgentsSCIENTIFIC REPORTSIF3.92016-12-1353OAAI
Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer MechanismsCHEMISTRY-A EUROPEAN JOURNALIF3.72016-04-2396PREAI
Cyclometalated iridium(III) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agentsCHEMICAL SCIENCEIF7.42015-01-01324OAAI
Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapyCHEMICAL COMMUNICATIONSIF4.22014-07-30122PREAI